Emerging Immunotherapy for Acute Myeloid Leukemia

Several immune checkpoint molecules and immune targets in leukemic cells have been investigated. Recent studies have suggested the potential clinical benefits of immuno-oncology (IO) therapy against acute myeloid leukemia (AML), especially targeting CD33, CD123, and CLL-1, as well as immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabata, Rikako, Chi, SungGi, Yuda, Junichiro, Minami, Yosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920435/
https://www.ncbi.nlm.nih.gov/pubmed/33669431
http://dx.doi.org/10.3390/ijms22041944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920435/
https://www.ncbi.nlm.nih.gov/pubmed/33669431
http://dx.doi.org/10.3390/ijms22041944

Ejemplares similares